{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T16:54:51Z","timestamp":1783875291746,"version":"3.55.0"},"reference-count":17,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.2217\/fon-2022-1133","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:12:56Z","timestamp":1675782776000},"page":"217-228","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9464-3984","authenticated-orcid":false,"given":"Paul K","family":"Paik","sequence":"first","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center,\r1275 York Avenue,\rManhattan,\rNY 10065,\rUSA"},{"name":"Weill Cornell Medical College,\r1300 York Avenue,\rNew York,\rNY10065,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-036X","authenticated-orcid":false,"given":"Ravi K","family":"Goyal","sequence":"additional","affiliation":[{"name":"RTI Health Solutions,\r3040 E Cornwallis Road, Research Triangle Park,\rNC 27709,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2762-3908","authenticated-orcid":false,"given":"Beilei","family":"Cai","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation,\r1 Health Plaza,\rEast Hanover,\rNJ07936,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Price","sequence":"additional","affiliation":[{"name":"RTI Health Solutions,\r3040 E Cornwallis Road, Research Triangle Park,\rNC 27709,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0044-7107","authenticated-orcid":false,"given":"Keith L","family":"Davis","sequence":"additional","affiliation":[{"name":"RTI Health Solutions,\r3040 E Cornwallis Road, Research Triangle Park,\rNC 27709,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-975X","authenticated-orcid":false,"given":"Valerie Derrien","family":"Ansquer","sequence":"additional","affiliation":[{"name":"RTI Health Solutions,\r3040 E Cornwallis Road, Research Triangle Park,\rNC 27709,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nydia","family":"Caro","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation,\r1 Health Plaza,\rEast Hanover,\rNJ07936,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy R","family":"Saliba","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation,\r1 Health Plaza,\rEast Hanover,\rNJ07936,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_7_4_1","unstructured":"Surveillance Epidemiology and End Results Program (SEER)\n. Cancer stat facts: lung and bronchus cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/lungb.html (Accessed 20July2022)."},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020612"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.06.002"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2019.1643239"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-0723-5"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002787"},{"key":"e_1_3_7_10_1","volume-title":"AACR Annual Meeting 2020.","author":"Garon EB","year":"2020","unstructured":"Garon EB , HeistRS, SetoTet al. CT082 - Capmatinib in METex14-mutated (mut) advanced non-small-cell lung cancer (NSCLC): results from the phase II GEOMETRY mono-1 study, including efficacy in patients (pts) with brain metastases (BM). Presented at: AACR Annual Meeting 2020. (2020). Virtual."},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.9004"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.09.127"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.03.006"},{"key":"e_1_3_7_14_1","unstructured":"US Food and Drug Administration\n. Cancer clinical trial eligibility criteria: brain metastases guidance for industry (2020). www.fda.gov\/media\/121317\/download"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70057-4"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2022.01.002"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0317"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88453-8"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2022-1133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:45Z","timestamp":1719125205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2022-1133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.2217\/fon-2022-1133"],"URL":"https:\/\/doi.org\/10.2217\/fon-2022-1133","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}